Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CFO resigned
CC transcript
Appointed director
OSIRIS THERAPEUTICS, INC. (OSIR) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/06/2015 8-K Quarterly results
Docs: "Osiris Therapeutics Announces Third Quarter 2015 Financial Results COLUMBIA, Md. — November 6, 2015 - Osiris Therapeutics, Inc. , the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the third quarter of 2015. Highlights and Recent Developments"
08/05/2015 8-K Quarterly results
Docs: "Osiris Therapeutics Announces Second Quarter 2015 Financial Results COLUMBIA, Md. —August 5, 2015 - Osiris Therapeutics, Inc. , the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the second quarter of 2015. Second Quarter Highlights and Developments"
05/08/2015 8-K Quarterly results
Docs: "Osiris Therapeutics Announces First Quarter 2015 Financial Results. COLUMBIA, Md. — May 8, 2015 - Osiris Therapeutics, Inc. , the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the first quarter of 2015. Highlights and Recent Developments"
03/05/2015 8-K Quarterly results
Docs: "Osiris Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results: For the Full Year, Revenue Increased 146% and Company Reports Record Revenue in Fourth Quarter. COLUMBIA, Md. — March 5, 2015 - Osiris Therapeutics, Inc. , the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the fourth quarter and full year ended December 31, 2014. Full Year and Fourth Quarter Highlights"
11/07/2014 8-K Quarterly results
Docs: "Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable COLUMBIA, Md. — November 7, 2014 - Osiris Therapeutics, Inc. , the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine, announced today its financial results for the third quarter of 2014. Highlights and Recent Developments"
08/07/2014 8-K Quarterly results
Docs: "Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter COLUMBIA, Md. — August 7, 2014 - Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets announced today its financial results for the second quarter of 2014. Highlights and Recent Developments"
05/12/2014 8-K Quarterly results
Docs: "Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78% COLUMBIA, Md. — May 12, 2014 - Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets announced today its financial results for the first quarter of 2014. Highlights and Recent Developments"
03/05/2014 8-K Quarterly results
Docs: "Osiris Therapeutics Reports Full Year 2013 and Fourth Quarter Financial Results: For the Full Year, Revenue Increased 3-Fold, Company was Profitable and Ended with Assets of $92.0 Million COLUMBIA, Md. — March 5, 2014 - Osiris Therapeutics, Inc. the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced today its results for the fourth quarter and full year ended December 31, 2013. Recent and Full Year Highlights"
11/01/2013 8-K Form 8-K - Current report
08/05/2013 8-K Form 8-K - Current report
05/07/2013 8-K Form 8-K - Current report
03/06/2013 8-K Form 8-K - Current report
11/05/2012 8-K Form 8-K - Current report
07/30/2012 8-K Form 8-K - Current report
05/11/2012 8-K Form 8-K - Current report
03/09/2012 8-K Form 8-K - Current report
11/04/2011 8-K Form 8-K - Current report
08/05/2011 8-K Form 8-K - Current report
05/09/2011 8-K Form 8-K - Current report
03/07/2011 8-K Form 8-K - Current report
11/05/2010 8-K Form 8-K - Current report
08/06/2010 8-K Form 8-K - Current report
05/07/2010 8-K Form 8-K - Current report
11/04/2009 8-K Form 8-K - Current report
08/06/2009 8-K Form 8-K - Current report
05/07/2009 8-K Form 8-K - Current report
11/04/2008 8-K Form 8-K - Current report
08/07/2008 8-K Form 8-K - Current report
05/09/2008 8-K Form 8-K - Current report
11/13/2007 8-K Form 8-K - Current report
08/09/2007 8-K Form 8-K - Current report
05/14/2007 8-K Form 8-K - Current report
02/20/2007 8-K Form 8-K - Current report
11/02/2006 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy